The coexpression of these two markers on the cell surface has been observed in a new subset of activated CD8 T cells (Ferguson and Engelhard, 2010), but the involvement of these cells in MS immunopathology has never been described. The gene discussed is CD8A; the disease is myeloid sarcoma.